Blog
Clinical Trial Phase
Articles filed under Clinical Trial Phase, newest first.
Latest article
How to Spot Acquisition Targets Before They Reach Phase III Clinical Trials
Learn how pharma companies can identify promising acquisition targets before Phase III by analyzing clinical trials, drug pipelines, biomarkers, scientific evidence, and strategic fit.
Read article
Strategic Advantages of Drug Pipeline Intelligence for Pharma Manufacturers
This post isn't about defining what pipeline intelligence is. It's about what it does, specifically, the seven strategic advantages it gives pharma manufacturers who choose to act on it rather than admire it from a distance.
Read article
Phase I drugs: Drug formulations in the lab to human testing
Explore how Phase I drug formulations transition from lab research to human testing, shaping the foundation for safe and effective clinical development.
Read article
Clinical Research Phases and the Path to Drug Approval
Discover the key phases of clinical research and the rigorous path to drug approval, ensuring safety, efficacy, and regulatory compliance in the pharmaceutical industry.
Read article
Developing Formulations for Phase 1 Clinical Trials
Explore key strategies for developing formulations for Phase 1 clinical trials, focusing on safety, efficacy, and regulatory considerations in drug development.
Read article